CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Scientific Reports

Topics

Biology

Biochemistry

Chemistry

Cancer Oncology

Immunology

Show all topics

DOI

10.1038/s41598-017-00462-8

License

CC-BY

Other Formats

PDF